Sprains and strains
Drug research and approvals for sprains and strains: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 74 studies of sprains and strains are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 74
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- A RANDOMİZED CONTROLLED TRİAL COMPARİNG THE EFFECTİVENESS OF MYOFASCİAL RELEASE, LOW-LEVEL LASER THERAPY, AND PELOİD…NCT07947316 · Not applicable · Konya Beyhekim Training and Research Hospital · starts Mar 5, 2026
- Injury Risks Among Acrobatic Gymnastics in Relation to Balance TrainingNCT07930949 · Not reported · Istanbul Galata University · starts May 29, 2025
- Exercise Therapy and Physical Activity Modification for Patients With Sever's DiseaseNCT07928232 · Phase 2 · California State University, Fullerton · starts Oct 30, 2025
- Comparison of Kinesio Taping Techniques in Ulnar Nerve EntrapmentNCT07863830 · Not applicable · Antalya Training and Research Hospital · starts Oct 9, 2026
- Ultrasound-Guided Injection of Carpal Tunnel Syndrome Using Hyaluronic Acid vs Corticosteroid vs Glucose 5%NCT07825155 · Early Phase 1 · Tanta University · starts Mar 15, 2026
- Open vs. Ultrasound-Guided Carpal Tunnel ReleaseNCT07814547 · Not reported · AUVA General Trauma Hospital Salzburg · starts Jun 1, 2026
- The Effects of Vestibulo-Ocular Reflex Exercises Added to Postural Stabilization Training in Amateur Athletes With…NCT07760233 · Not applicable · Bahçeşehir University · starts Jul 25, 2026
- The Effects of Vestibulo-Ocular Reflex Exercises Added to Postural Stabilization Training in Chronic Ankle InstabilityNCT07728526 · Not applicable · Bahçeşehir University · starts Jul 22, 2026
- Effectiveness of Amniotic Membrane Combined With Secretome as an Adjunct to Carpal Tunnel Release Surgery: Evaluation…NCT07723313 · Early Phase 1 · PT. Prodia Stem Cell Indonesia · starts Dec 15, 2025
Approved 10
- DiclofenacCyclooxygenase inhibitor
- LidocaineSodium channel alpha subunit blocker
- Zinc oxideSunscreen/skin protectant
- MentholTransient receptor potential cation channel subfamily M member 8 opener
- CapsaicinVanilloid receptor opener
- CefaclorBacterial penicillin-binding protein inhibitor
- CephalexinBacterial penicillin-binding protein inhibitor
- CefepimeBacterial penicillin-binding protein inhibitor
- Methyl salicylate
- Camphor
Phase 3 6
- KetoprofenCyclooxygenase inhibitor
- EtodolacCyclooxygenase-2 inhibitor
- IbuprofenCyclooxygenase inhibitor
- OnabotulinumtoxinaSynaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
- AllopurinolXanthine dehydrogenase inhibitor
- Diethylamine
Phase 2 1
- EsflurbiprofenCyclooxygenase inhibitor
How its trials ended
200 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 33 whose ending is known, 33% met their primary endpoint, 12% missed it and 55% stopped early.
- Completed, result not reported9648%
- Ongoing4020%
- Status unknown3116%
- Met its primary endpoint116%
- Stopped: other or unclear116%
- Missed its primary endpoint42%
- Stopped: sponsor or business decision32%
- Stopped: lack of efficacy21%
- Stopped: enrollment or feasibility21%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA